Insight

Northleaf Capital collects $212m for growth equity fund

Northleaf Growth Fund targets growth-stage companies in North America across the technology and healthcare sectors.

-
  • Northleaf’s investments include BlueCat Networks, eSentire, Verafin and Zymeworks
  • Based in Toronto, Northleaf has raised more than $24 billion to date
  • Northleaf invests in the middle market

Northleaf Capital Partners has closed its first direct growth equity fund at $212 million, beating its $200 million target.

Northleaf Growth Fund targets growth-stage companies in North America across the technology and healthcare sectors.

“We are very pleased by the strong support from both new and existing investors in our growth fund,” said Mike Flood, managing director and head of private equity at Northleaf in a statement. “Investors in our growth equity strategy benefit from the direct and secondary investment capabilities of the broader Northleaf global platform.”

Northleaf’s investments include BlueCat Networks, eSentire, Verafin and Zymeworks.

Based in Toronto, Northleaf has raised more than $24 billion to date. Northleaf invests in the middle market.